Profile of neratinib and its potential in the treatment of breast cancer
Katharina Feldinger,1 Anthony Kong,2 1Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, 2The Robert Aitkin Institute, School of Cancer Sciences, University of Birmingham, Birmingham, UK Abstract: The HER (ErbB) receptor tyrosine kinase receptors a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-06-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Online Access: | http://www.dovepress.com/profile-of-neratinib-and-its-potential-in-the-treatment-of-breast-canc-peer-reviewed-article-BCTT |